Skip to main content

Advertisement

Table 6 Factors that influence bleeding as side effect by stepwise logistic regression method

From: Retrospective cohort study of the efficacy and safety of dabigatran: real-life dabigatran use including very low-dose 75 mg twice daily administration

Factor Adjusted ODDS ratio 95% CI P-value
New users 0.51 0.27–0.91 0.022*
A: Aged 75 or older 1.55 0.87–2.79 0.136
S: Stroke/TIA 1.71 0.94–3.07 0.081
With antiplatelet agents 2.04 1.07–3.75 0.030*
  1. *P < 0.05